$RPID News

Keybanc Maintains Overweight on Rapid Micro Biosystems, Lowers Price Target to $5

Lake Street Maintains Buy on Rapid Micro Biosystems, Lowers Price Target to $7

Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript

Rapid Micro Biosystems Inc-A (NASDAQ:RPID) Q1 2026: Revenue Beats Street, But EPS Miss Clouds Outlook

Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript

Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.225M Est

Rapid Micro Biosystems Q1 EPS $(0.31) Misses $(0.23) Estimate, Sales $8.002M Beat $7.600M Estimate

Rapid Micro Biosystems: Big Pharma Adoption Driving Growth

Rapid Micro Biosystems Inc (NASDAQ:RPID) Reports Record Q4 Revenue but Misses Estimates, Shares Drop 9%

Rapid Micro Biosystems, Inc. (RPID) Q4 2025 Earnings Call Transcript

Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform

Rapid Micro Biosystems shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint below estimates.

Rapid Micro Biosystems shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint below estimates.

Rapid Micro Biosystems Sees FY2026 Sales $37.000M-$41.000M vs $40.125M Est

Rapid Micro Biosystems Q4 EPS $(0.28) Misses $(0.22) Estimate, Sales $11.282M Miss $11.350M Estimate

Rapid Micro Biosystems Announces Follow-On Multi-System Order From Samsung Biologics To Expand Deployment Of Growth Direct Platform

Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum

Rapid Micro Biosystems, Inc. (RPID) Presents at TD Cowen 46th Annual Health Care Conference - Slideshow

Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026